← FDATracker
HomeAdverse Events

ZYTIGA 250MG JANSSEN BIOTECH Adverse Event: Disease progression

ZYTIGA 250MG JANSSEN BIOTECH Adverse Event: Disease progression is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: ZYTIGA 250MG JANSSEN BIOTECH; Product category: Drug; Primary reaction: Disease progression.

Primary drugZYTIGA 250MG JANSSEN BIOTECH
Product categoryDrug
Primary reactionDisease progression
All reactionsDisease progression
SeriousnessSerious
Patient outcomeUnknown
Patient sexMale
All drugs reportedZYTIGA 250MG JANSSEN BIOTECH
Reporter countryUS
Reporter type2
Report date20140312
Report ID10007206

🔍 Search all adverse events →